VIM
REGN icon

Vinva Investment Management’s Regeneron Pharmaceuticals REGN Stock Holding History

Vinva Investment Management’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$21.8M Buy
34,494
+19,632
+132% +$13.4M 0.14% 146
2026
Q1 		$11.1M Buy
14,862
+972
+7% +$744K 0.14% 166
2025
Q4 		$10.8M Buy
13,890
+5,115
+58% +$3.47M 0.13% 155
2025
Q3 		$4.92M Buy
8,775
+2,093
+31% +$1.18M 0.1% 184
2025
Q2 		$3.48M Buy
6,682
+1,182
+21% +$660K 0.09% 194
2025
Q1 		$3.51M Buy
5,500
+1,721
+46% +$1.18M 0.14% 169
2024
Q4 		$2.66M Buy
3,779
+1,182
+46% +$992K 0.1% 195
2024
Q3 		$2.71M Sell
2,597
-1,055
-29% -$1.17M 0.11% 189
2024
Q2 		$3.84M Sell
3,652
-405
-10% -$393K 0.19% 126
2024
Q1 		$3.9M Buy
4,057
+359
+10% +$341K 0.22% 119
2023
Q4 		$3.26M Buy
3,698
+530
+17% +$436K 0.22% 114
2023
Q3 		$2.64M Sell
3,168
-10
-0.3% -$7.86K 0.25% 102
2023
Q2 		$2.25M Sell
3,178
-475
-13% -$366K 0.19% 129
2023
Q1 		$2.96M Buy
+3,653
New +$2.76M 0.25% 107

Other funds holding REGN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Vinva Investment Management's REGN Position: Q2 2026 in Review

Vinva Investment Management increased its Regeneron Pharmaceuticals (REGN) stake by 132% in Q2 2026, buying an estimated $13.4M and bringing the position to 34,494 shares worth $21.8M. The position accounts for 0.14% of the portfolio, ranked #146.

Vinva Investment Management first reported a position in REGN in Q1 2023 and has held it in 14 quarters since. 1,340 funds tracked by Wall St. Rank hold REGN as of Q2 2026.

  • Vinva Investment Management held 34,494 shares of Regeneron Pharmaceuticals worth $21.8M as of Q2 2026.
  • Vinva Investment Management bought 19,632 Regeneron Pharmaceuticals shares in Q2 2026, an estimated $13.4M.
  • Regeneron Pharmaceuticals made up 0.14% of Vinva Investment Management's portfolio in Q2 2026, its #146 holding.
  • Vinva Investment Management first reported a position in Regeneron Pharmaceuticals in Q1 2023 and has held it in 14 quarters since.
  • 1,340 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.

Based on Vinva Investment Management's 13F filing for Q2 2026, filed 14 Aug 2026.